MacroGenics Inc (MGNX) stock
MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.17−0.03 (-1.36%)
Close on Nov 16, 2026Market cap $138.23MP/E –Yield –
MacroGenics cash
Cash and short-term investments held at the end of each period.
MacroGenics's cash was $113.91M at Jun 30, 2026. For fiscal 2025 it was $57.22M, down 68.7% from the year before. Over ten years it grew -11.6% a year on average. The highest annual figure on record is $220.13M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.22M | -68.7% |
| FY2024 | Dec 31, 2024 | $182.84M | +81.1% |
| FY2023 | Dec 31, 2023 | $100.96M | -7.3% |
| FY2022 | Dec 31, 2022 | $108.88M | -11.8% |
| FY2021 | Dec 31, 2021 | $123.47M | -31.8% |
| FY2020 | Dec 31, 2020 | $181.13M | +43.2% |
| FY2019 | Dec 31, 2019 | $126.47M | -42.5% |
| FY2018 | Dec 31, 2018 | $220.13M | +4.0% |
| FY2017 | Dec 31, 2017 | $211.73M | +151.8% |
| FY2016 | Dec 31, 2016 | $84.10M | -57.1% |
| FY2015 | Dec 31, 2015 | $196.17M | +24.5% |
| FY2014 | Dec 31, 2014 | $157.59M | +35.3% |
| FY2013 | Dec 31, 2013 | $116.48M | +144.0% |
| FY2012 | Dec 31, 2012 | $47.74M | -13.5% |
| FY2011 | Dec 31, 2011 | $55.22M | +49.7% |
| FY2010 | Dec 31, 2010 | $36.88M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $113.91M | -12.8% |
| Q1 FY2026 | Mar 31, 2026 | $66.52M | -54.3% |
| Q4 FY2025 | Dec 31, 2025 | $57.22M | -68.7% |
| Q3 FY2025 | Sep 30, 2025 | $80.13M | -55.4% |
| Q2 FY2025 | Jun 30, 2025 | $130.69M | +55.7% |
| Q1 FY2025 | Mar 31, 2025 | $145.57M | +81.2% |
| Q4 FY2024 | Dec 31, 2024 | $182.84M | +81.1% |
| Q3 FY2024 | Sep 30, 2024 | $179.63M | +99.8% |
| Q2 FY2024 | Jun 30, 2024 | $83.93M | -22.8% |
| Q1 FY2024 | Mar 31, 2024 | $80.36M | -64.2% |
| Q4 FY2023 | Dec 31, 2023 | $100.96M | -7.3% |
| Q3 FY2023 | Sep 30, 2023 | $89.90M | +7.0% |
| Q2 FY2023 | Jun 30, 2023 | $108.76M | +406.6% |
| Q1 FY2023 | Mar 31, 2023 | $224.26M | +373.9% |
| Q4 FY2022 | Dec 31, 2022 | $108.88M | -11.8% |
| Q3 FY2022 | Sep 30, 2022 | $83.99M | -55.9% |
| Q2 FY2022 | Jun 30, 2022 | $21.47M | -88.6% |
| Q1 FY2022 | Mar 31, 2022 | $47.33M | -78.3% |
| Q4 FY2021 | Dec 31, 2021 | $123.47M | -31.8% |
| Q3 FY2021 | Sep 30, 2021 | $190.53M | -5.5% |
| Q2 FY2021 | Jun 30, 2021 | $188.97M | -3.8% |
| Q1 FY2021 | Mar 31, 2021 | $218.50M | +134.8% |
| Q4 FY2020 | Dec 31, 2020 | $181.13M | +43.2% |
| Q3 FY2020 | Sep 30, 2020 | $201.64M | +28.8% |
| Q2 FY2020 | Jun 30, 2020 | $196.53M | +9.0% |
| Q1 FY2020 | Mar 31, 2020 | $93.06M | -61.0% |
| Q4 FY2019 | Dec 31, 2019 | $126.47M | -42.5% |
| Q3 FY2019 | Sep 30, 2019 | $156.59M | -22.4% |
| Q2 FY2019 | Jun 30, 2019 | $180.32M | -24.4% |
| Q1 FY2019 | Mar 31, 2019 | $238.64M | +19.1% |
| Q4 FY2018 | Dec 31, 2018 | $220.13M | +4.0% |
| Q3 FY2018 | Sep 30, 2018 | $201.81M | +122.0% |
| Q2 FY2018 | Jun 30, 2018 | $238.66M | +104.6% |
| Q1 FY2018 | Mar 31, 2018 | $200.45M | +394.7% |
| Q4 FY2017 | Dec 31, 2017 | $211.73M | +151.8% |
| Q3 FY2017 | Sep 30, 2017 | $90.88M | -17.3% |
| Q2 FY2017 | Jun 30, 2017 | $116.63M | – |
| Q1 FY2017 | Mar 31, 2017 | $40.52M | – |
| Q4 FY2016 | Dec 31, 2016 | $84.10M | – |
| Q3 FY2016 | Sep 30, 2016 | $109.90M | – |
See a number that looks wrong?